When deciding on the optimal revascularization strategy for patients with multivessel coronary disease, a noninvasive approach using quantitative flow ratio (QFR) showed substantial agreement with the more invasive classical fractional flow reserve (FFR) approach in a new study.
The DECISION-QFR study was presented by Taku Asano, MD, St. Luke's International Hospital, Tokyo, Japan, at the Congress of the European Association of Percutaneous Coronary Interventions (EuroPCR) 2022, being held this week in Paris
